<DOC>
	<DOCNO>NCT01820429</DOCNO>
	<brief_summary>The purpose study compare response aspirin acute phase late phase acute coronary syndrome .</brief_summary>
	<brief_title>Residual Platelet Activity Despite Aspirin Utilization Coronary Heart Disease</brief_title>
	<detailed_description>The purpose study compare , population , response aspirin initial phase ( first 48 hour ) late phase ( 3 month discharge ) non ST elevation acute coronary syndrome ( angina acute myocardial infarction ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Age â‰¥ 18 year Confirmed diagnosis acute coronary syndrome without ST segment elevation , first 48 hour onset clinical symptom Regular use aspirin least seven day . Previous use , last 7 day , another antiplatelet agent aspirin Use antivitamin K last 3 week Hemoglobin &lt; 10g/dL / hematocrit &lt; 30 % &gt; 50 % , platelet count &lt; 100.000/mm3 &gt; 500.000/mm3 , creatinine clearance &lt; 30 mL / minute Killip class III IV Need vasopressor inotropic parenteral medication inclusion study Percutaneous coronary intervention within 30 day CABG last 90 day prior study entry Current malignancy Hematologic diseases Refusal sign inform consent form Unable attend second visit ( followup ) reason except death</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Platelet aggregation</keyword>
	<keyword>Aspirin</keyword>
</DOC>